美国第五代气球膨胀阀TAVR的一年实际效果

JACC: Cardiovascular Interventions Pub Date : 2024-11-24 DOI:10.1016/j.jcin.2024.11.015

Annapoorna S. Kini MD, Gilbert H.L. Tang MD MSc MBA, Ricardo Yaryura MD, George Petrossian MD, David K. Roberts MD, Ayaz Rahman MD, Adam Saltzman MD, Raymond Durkin MD, James T. DeVries MD, Curtiss Stinis MD

{"title":"美国第五代气球膨胀阀TAVR的一年实际效果","authors":"Annapoorna S. Kini MD, Gilbert H.L. Tang MD MSc MBA, Ricardo Yaryura MD, George Petrossian MD, David K. Roberts MD, Ayaz Rahman MD, Adam Saltzman MD, Raymond Durkin MD, James T. DeVries MD, Curtiss Stinis MD","doi":"10.1016/j.jcin.2024.11.015","DOIUrl":null,"url":null,"abstract":"Longer term outcomes of transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 Ultra RESILIA (S3UR) valve over its predecessors have not been reported in a national registry.","PeriodicalId":14666,"journal":{"name":"JACC: Cardiovascular Interventions","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"One-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States\",\"authors\":\"Annapoorna S. Kini MD, Gilbert H.L. Tang MD MSc MBA, Ricardo Yaryura MD, George Petrossian MD, David K. Roberts MD, Ayaz Rahman MD, Adam Saltzman MD, Raymond Durkin MD, James T. DeVries MD, Curtiss Stinis MD\",\"doi\":\"10.1016/j.jcin.2024.11.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Longer term outcomes of transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 Ultra RESILIA (S3UR) valve over its predecessors have not been reported in a national registry.\",\"PeriodicalId\":14666,\"journal\":{\"name\":\"JACC: Cardiovascular Interventions\",\"volume\":\"32 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Cardiovascular Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcin.2024.11.015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Cardiovascular Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcin.2024.11.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

经导管主动脉瓣置换术（TAVR）使用SAPIEN 3 Ultra RESILIA （S3UR）瓣膜的长期疗效优于其前身，尚未在国家登记中报道。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

One-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States

Longer term outcomes of transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 Ultra RESILIA (S3UR) valve over its predecessors have not been reported in a national registry.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JACC: Cardiovascular Interventions

自引率

0.00%

发文量